Literature DB >> 1577619

Immunofluorescent localization of pig complement component 3, regardless of the presence or absence of detectable immunoglobulins, in hyperacutely rejected heart xenografts.

M W Wang1, P S Johnston, L J Wright, S M Lim, D J White.   

Abstract

Rabbit heart xenografts transplanted into the neck of newborn pigs were all hyperacutely rejected within two hours regardless of the presence or absence of detectable endogenous immunoglobulins (Ig). Cryostat tissue sections were prepared from the rejected rabbit hearts and incubated with sheep polyclonal antibodies against pig complement component 3 (C3), pig IgG and pig IgM. Specific immunoreaction was visualized by fluorescein-conjugated antibodies to sheep IgG. C3 was localized mainly on the surfaces of vascular endothelial as well as myocardial cells, and the localization was not dependent upon the presence of pig immunoglobulins within the same tissue. Both pig IgG and IgM were detected only in the heart xenografts transplanted into suckled pigs, whereas no trace of immunoglobulin was found in those transplanted into circulating antibody-free presuckled pigs. Treatment with cobra venom factor (which inhibits complement activity) prior to transplantation prolonged xenograft survival and completely abolished C3 immunostaining. The results provide new evidence at the histochemical level that the alternative pathway of complement is involved in hyperacute xenograft rejection of the species combination (rabbit to pig) used in this study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577619     DOI: 10.1007/bf01082446

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  33 in total

1.  THE IMMUNOLOGIC BEHAVIOR OF BABY PIGS. IV. INTESTINAL ABSORPTION AND PERSISTANCE OF 6.6S AND 18S ANTIBODIES OF OVINE ORIGIN AND THEIR ROLE IN THE IMMUNOLOGIC COMPETENCE OF BABY PIGS.

Authors:  R F LOCKE; W L MYERS; D SEGRE
Journal:  J Immunol       Date:  1964-10       Impact factor: 5.422

Review 2.  Transplantation of discordant xenografts: a review of progress.

Authors:  J L Platt; G M Vercellotti; A P Dalmasso; A J Matas; R M Bolman; J S Najarian; F H Bach
Journal:  Immunol Today       Date:  1990-12

3.  Hyperacute rejection of xenografts in the complete absence of antibody.

Authors:  P S Johnston; S M Lim; M W Wang; L Wright; D J White
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 4.  Immunology of xenograft rejection.

Authors:  D H Sachs; F H Bach
Journal:  Hum Immunol       Date:  1990-06       Impact factor: 2.850

Review 5.  The multifunctional role of C3, the third component of complement.

Authors:  J D Lambris
Journal:  Immunol Today       Date:  1988-12

6.  The mechanism of discordant xenograft rejection.

Authors:  S Miyagawa; H Hirose; R Shirakura; Y Naka; S Nakata; Y Kawashima; T Seya; M Matsumoto; A Uenaka; H Kitamura
Journal:  Transplantation       Date:  1988-12       Impact factor: 4.939

7.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

8.  Heterophile antibodies in man.

Authors:  A R Shons; C Kromrey; J S Najarian
Journal:  Eur Surg Res       Date:  1973       Impact factor: 1.745

9.  [Further in-vitro studies on the mechanism of hyperacute xenogenic rejection reaction (HXAR)].

Authors:  E Pratschke; W Land; A Schilling; K Pielsticker; W Brendel
Journal:  Langenbecks Arch Chir       Date:  1975

10.  Organ transplantation between widely disparate species.

Authors:  R Y Calne
Journal:  Transplant Proc       Date:  1970-12       Impact factor: 1.066

View more
  2 in total

1.  Solution structure of Compstatin, a potent complement inhibitor.

Authors:  D Morikis; N Assa-Munt; A Sahu; J D Lambris
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

Review 2.  Therapeutic uses of recombinant complement protein inhibitors.

Authors:  K R Kalli; P Hsu; D T Fearon
Journal:  Springer Semin Immunopathol       Date:  1994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.